Unravelling the proteome of degenerative human mitral valves
- 24 April 2015
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 15 (17) , 2934-2944
Abstract
Degenerative mitral valve disease (DMVD), which includes the syndromes of mitral valve prolapse (MVP) and flail leaflet, is a common valvular condition which can be complicated by mitral regurgitation and adverse cardiovascular outcomes. Although several genetic and other studies of MVP in dog models have provided some information regarding the underlying disease mechanisms, the proteins and molecular events mediating human MVP pathogenesis have not been unraveled. In this study, we report the first large‐scale proteome profiling of mitral valve tissue resected from patients with MVP. A total of 1134 proteins were identified, some of which were validated using SWATH‐MS and western blotting. GO annotation of these proteins confirmed the validity of this proteome database in various cardiovascular processes. Among the list of proteins, we found several structural and extracellular matrix proteins, such as asporin, biglycan, decorin, lumican, mimecan, prolargin, versican, and vinculin, that have putative roles in the pathophysiology of MVP. These proteins could also be involved in the cardiac remodeling associated with mitral regurgitation. All MS data have been deposited in the ProteomeXchange with identifier PXD000774 (http://proteomecentral.proteomexchange.org/dataset/PXD000774).Keywords
Funding Information
- Singapore National Medical Research Council (NMRC/CG/NUHCS/2010/Theme 4)
This publication has 41 references indexed in Scilit:
- Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapseJournal of Proteomics, 2013
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013Nucleic Acids Research, 2012
- Mitral Valve ProlapseAnnual Review of Medicine, 2012
- Mitral valve prolapse is the commonest cause of mitral regurgitation in contemporary ChinaInternational Journal of Cardiology, 2011
- Differential protein expression between normal, early‐stage, and late‐stage myxomatous mitral valves from dogsProteomics – Clinical Applications, 2009
- Biobanking for better healthcareMolecular Oncology, 2008
- Quantitative and Temporal Proteome Analysis of Butyrate-treated Colorectal Cancer CellsMolecular & Cellular Proteomics, 2008
- Etiologic Classification of Degenerative Mitral Valve Disease: Barlow’s Disease and Fibroelastic DeficiencySeminars in Thoracic and Cardiovascular Surgery, 2007
- Prevalence and Clinical Outcome of Mitral-Valve ProlapseNew England Journal of Medicine, 1999
- Clinical Outcome of Mitral Regurgitation Due to Flail LeafletNew England Journal of Medicine, 1996